Hereditary pancreatic cancer

Gastroenterology

Volumn 139, Issue 4, 2010, Pages

  Grover, Shilpa ^a,b,c,d   Syngal, Sapna ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P16;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILIAL CANCER; FAMILIAL PANCREATIC CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; OVARY CANCER; PANCREAS CANCER; PANCREATITIS; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; CHRONIC PANCREATITIS; DYSPLASTIC NEVUS; GENETICS; PANCREATIC NEOPLASMS;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DYSPLASTIC NEVUS SYNDROME; EARLY DETECTION OF CANCER; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PEUTZ-JEGHERS SYNDROME;

EID: 77957353339     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.012     Document Type: Article

References (85)

1. American Cancer Society Cancer Facts and Figures 2010 http://www.cancer.org/docroot/STT/content/STT-1x-Cancer-Facts-Figures-2010.asp Accessed June 2010
2. H. Furukawa, S. Okada, and H. Saisho Clinicopathologic features of small pancreatic adenocarcinoma A collective study Cancer 78 1996 986 990
3. H.T. Lynch, T. Smyrk, and S.E. Kern Familial pancreatic cancer: a review Semin Oncol 23 1996 251 275
4. R.E. Brand, and H.T. Lynch Hereditary pancreatic adenocarcinoma A clinical perspective Med Clin North Am 84 2000 665 675
5. H.T. Lynch, A.J. Krush, and A.L. Larsen Heredity and multiple primary malignant neoplasms: six cancer families Am J Med Sci 254 1967 322 329
6. R.P. MacDermott, and P. Kramer Adenocarcinoma of the pancreas in four siblings Gastroenterology 65 1973 137 139
7. D. Ehrenthal, L. Haeger, T. Griffin, and C. Compton Familial pancreatic adenocarcinoma in three generations A case report and a review of the literature Cancer 59 1987 1661 1664
8. R.R. Reimer, J.F. Fraumeni Jr., R.F. Ozols, and R. Bender Pancreatic cancer in father and son Lancet 1 1977 911
9. J.M. Friedman, and P.J. Fialkow Carcinoma of the pancreas in four brothers Birth Defects Orig Artic Ser 12 1976 145 150
10. N.M. Dat, and S.J. Sontag Pancreatic carcinoma in brothers Ann Intern Med 97 1982 282
11. N. Katkhouda, and J. Mouiel Pancreatic cancer in mother and daughter Lancet 2 1986 747
12. P. Ghadirian, P. Boyle, and A. Simard Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada Int J Pancreatol 10 1991 183 196
13. D.T. Silverman Risk factors for pancreatic cancer: a case-control study based on direct interviews Teratog Carcinog Mutagen 21 2001 7 25
14. S.S. Coughlin, E.E. Calle, and A.V. Patel Predictors of pancreatic cancer mortality among a large cohort of United States adults Cancer Causes Control 11 2000 915 923
15. K. Hemminki, and X. Li Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden Int J Cancer 103 2003 525 530 (Pubitemid 36020229)
16. A.P. Klein, T.H. Beaty, and J.E. Bailey-Wilson Evidence for a major gene influencing risk of pancreatic cancer Genet Epidemiol 23 2002 133 149
17. K.L. Pogue-Geile, R. Chen, and M.P. Bronner Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med 3 2006 e516
18. J. Earl, L. Yan, and L.J. Vitone Evaluation of the 4q32-34 locus in European familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 15 2006 1948 1955
19. E. Slater, V. Amrillaeva, and V. Fendrich Palladin mutation causes familial pancreatic cancer: absence in European families PLoS Med 4 2007 e164
20. A.P. Klein, M. de Andrade, and R.H. Hruban Linkage analysis of chromosome 4 in families with familial pancreatic cancer Cancer Biol Ther 6 2007 320 323
21. S.N. Salaria, P. Illei, and R. Sharma Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells Cancer Biol Ther 6 2007 324 328
22. S.A. Hahn, B. Greenhalf, and I. Ellis BRCA2 germline mutations in familial pancreatic carcinoma J Natl Cancer Inst 95 2003 214 221
23. K.M. Murphy, K.A. Brune, and C. Griffin Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% Cancer Res 62 2002 3789 3793
24. S. Jones, R.H. Hruban, and M. Kamiyama Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene Science 324 2009 217
25. A.P. Klein, K.A. Brune, and G.M. Petersen Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds Cancer Res 64 2004 2634 2638
26. W. Wang, S. Chen, and K.A. Brune PancPRO: risk assessment for individuals with a family history of pancreatic cancer J Clin Oncol 25 2007 1417 1422
27. E. Volikos, J. Robinson, and K. Aittomaki LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome J Med Genet 43 2006 e18
28. S. Aretz, D. Stienen, and S. Uhlhaas High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome Hum Mutat 26 2005 513 519
29. F.M. Giardiello, J.D. Brensinger, and A.C. Tersmette Very high risk of cancer in Peutz-Jeghers syndrome Gastroenterology 119 2000 1447 1453
30. N. Hearle, V. Schumacher, and F.H. Menko Frequency and spectrum of cancers in the Peutz-Jeghers syndrome Clin Cancer Res 12 2006 3209 3215
31. F.G. Haluska, and F.S. Hodi Molecular genetics of familial cutaneous melanoma J Clin Oncol 16 1998 670 682
32. A.M. Goldstein, M. Chan, and M. Harland Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents J Med Genet 44 2007 99 106
33. N. Soufir, M.F. Avril, and A. Chompret Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France The French Familial Melanoma Study Group Hum Mol Genet 7 1998 209 216
34. A. Kamb, D. Shattuck-Eidens, and R. Eeles Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus Nat Genet 8 1994 23 26
35. C.J. Hussussian, J.P. Struewing, and A.M. Goldstein Germline p16 mutations in familial melanoma Nat Genet 8 1994 15 21
36. H.T. Lynch, B.C. Frichot 3rd, and J.F. Lynch Familial atypical multiple mole-melanoma syndrome J Med Genet 15 1978 352 356
37. A.M. Goldstein, L.R. Goldin, and N.C. Dracopoli Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi Am J Hum Genet 58 1996 1050 1056
38. H.T. Lynch, R.M. Fusaro, and J.F. Lynch Pancreatic cancer and the FAMMM syndrome Fam Cancer 7 2008 103 112
39. H.T. Lynch, R.E. Brand, and D. Hogg Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome Cancer 94 2002 84 96
40. A.M. Goldstein, M.C. Fraser, and J.P. Struewing Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations N Engl J Med 333 1995 970 974
41. J.L. Rutter, C.M. Bromley, and A.M. Goldstein Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study Cancer 101 2004 2809 2816
42. H.T. Lynch, R.E. Brand, and J.F. Lynch Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families Gastroenterology 119 2000 1756 1760
43. F. Kastrinos, B. Mukherjee, and N. Tayob Risk of pancreatic cancer in families with Lynch syndrome JAMA 302 2009 1790 1795
44. H. Yamamoto, F. Itoh, and H. Nakamura Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability Cancer Res 61 2001 3139 3144
45. R.E. Wilentz, M. Goggins, and M. Redston Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity Am J Pathol 156 2000 1641 1651
46. M. Goggins, G.J. Offerhaus, and W. Hilgers Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ Am J Pathol 152 1998 1501 1507
47. O.M. Sinilnikova, S. Mazoyer, and C. Bonnardel BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families Fam Cancer 5 2006 15 20
48. M.S. Brose, T.R. Rebbeck, and K.A. Calzone Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 2002 1365 1372
49. D. Thompson, and D.F. Easton Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 2002 1358 1365 (Pubitemid 35154140)
50. S. Skudra, A. Staka, and A. Pukitis Association of genetic variants with pancreatic cancer Cancer Genet Cytogenet 179 2007 76 78
51. Breast Cancer Linkage Consortium Cancer Risks in BRCA2 Mutation Carriers J Natl Cancer Inst 91 1999 1310 1316
52. F.J. Couch, M.R. Johnson, and K.G. Rabe The prevalence of BRCA2 mutations in familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 16 2007 342 346
53. M. Goggins, M. Schutte, and J. Lu Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 1996 5360 5364
54. J.P. Struewing, D. Abeliovich, and T. Peretz The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nat Genet 11 1995 198 200
55. P. Hartge, J.P. Struewing, and S. Wacholder The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews Am J Hum Genet 64 1999 963 970
56. H. Ozcelik, B. Schmocker, and N. Di Nicola Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1997 17 18
57. B.B. Roa, A.A. Boyd, and K. Volcik Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 Nat Genet 14 1996 185 187
58. C.R. Ferrone, D.A. Levine, and L.H. Tang BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma J Clin Oncol 27 2009 433 438
59. N. Teich, J. Rosendahl, and M. Toth Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis Hum Mutat 27 2006 721 730
60. M. Sahin-Toth, and M. Toth Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen Biochem Biophys Res Commun 278 2000 286 289
61. N. Teich, Z. Nemoda, and H. Kohler Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl Hum Mutat 25 2005 343 347
62. A.B. Lowenfels, P. Maisonneuve, and E.P. DiMagno Hereditary pancreatitis and the risk of pancreatic cancer International Hereditary Pancreatitis Study Group J Natl Cancer Inst 89 1997 442 446
63. N. Howes, M.M. Lerch, and W. Greenhalf Clinical and genetic characteristics of hereditary pancreatitis in Europe Clin Gastroenterol Hepatol 2 2004 252 261
64. A.B. Lowenfels, P. Maisonneuve, and D.C. Whitcomb Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis JAMA 286 2001 169 170
65. C.F. Castillo, and N.V. Adsay Intraductal papillary mucinous neoplasms of the pancreas Gastroenterology 139 2010 708 713
66. R.H. Hruban, N.V. Adsay, and J. Albores-Saavedra Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
67. R.H. Hruban, K. Takaori, and D.S. Klimstra An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
68. T.A. Brentnall, M.P. Bronner, and D.R. Byrd Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer Ann Intern Med 131 1999 247 255
69. M.I. Canto, M. Goggins, and C.J. Yeo Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach Clin Gastroenterol Hepatol 2 2004 606 621
70. M.I. Canto, M. Goggins, and R.H. Hruban Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study Clin Gastroenterol Hepatol 4 2006 766 781
71. W.M. Steinberg, J.S. Barkin, and E.L. Bradley 3rd Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas? Pancreas 38 2009 e137 e150
72. J.B. Greer, H.T. Lynch, and R.E. Brand Hereditary pancreatic cancer: a clinical perspective Best Pract Res Clin Gastroenterol 23 2009 159 170
73. P. Langer, P.H. Kann, and V. Fendrich Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer Gut 58 2009 1410 1418
74. J. DeWitt, B. Devereaux, and M. Chriswell Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer Ann Intern Med 141 2004 753 763
75. G.P. Aithal, R.Y. Chen, and J.T. Cunningham Accuracy of EUS for detection of intraductal papillary mucinous tumor of the pancreas Gastrointest Endosc 56 2002 701 707
76. A.V. Biankin, J.G. Kench, and S.A. Biankin Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence Am J Surg Pathol 28 2004 1184 1192
77. K. Brune, T. Abe, and M. Canto Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer Am J Surg Pathol 30 2006 1067 1076
78. Y. Fukukura, F. Fujiyoshi, and H. Hamada Intraductal papillary mucinous tumors of the pancreas Comparison of helical CT and MR imaging Acta Radiol 44 2003 464 471
79. J. Albert, D. Schilling, and H. Breer Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography Endoscopy 32 2000 472 476
80. Y. Fukukura, F. Fujiyoshi, and M. Sasaki Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation Radiology 222 2002 674 680
81. R.E. Brand, M.M. Lerch, and W.S. Rubinstein Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut 56 2007 1460 1469
82. S.J. Rulyak, A.B. Lowenfels, and P. Maisonneuve Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds Gastroenterology 124 2003 1292 1299
83. H.C. Harsha, K. Kandasamy, and P. Ranganathan A compendium of potential biomarkers of pancreatic cancer PLoS Med 7 6 2009 e1000046
84. H.F. Vasen, N.A. Gruis, and R.R. Frants Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 15 87 2000 809 811
85. C.J. van Asperen, R.M. Brohet, and E.J. Meijers-Heijboer Cancer risks in BRCA2 families: estimates for sites other than breast and ovary J Med Genet 42 2005 711 719